FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to neurology and cardiology, and concerns treating a complication related to an aneurysmal subarachnoidal haemorrhage. That is ensured by determining the patient's plasma citrulline, and if observing a decrease thereof, an effective amount thereof is administered.
EFFECT: method provides effective treatment of such complication as the vasospasm by increasing the nitrogen oxide level.
16 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THERAPY OF PULMONARY DISEASES | 2009 |
|
RU2557048C2 |
| COMPOSITIONS AND METHODS FOR IMPROVEMENT OF FORECAST OF PERSON WITH SUBARACHNOIDAL HEMORRHAGE | 2012 |
|
RU2597791C2 |
| HAPTOGLOBIN FOR USE IN TREATMENT OF UNFAVORABLE SECONDARY NEUROLOGICAL OUTCOME FOLLOWING HAEMORRHAGIC STROKE | 2020 |
|
RU2818474C2 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF INFECTIOUS COMPLICATIONS AND SEPSIS IN NEUROSURGICAL PATIENTS WITH AN ANEURISMATIC CEREBROVASCULAR DISEASE IN AN ACUTE PERIOD OF ANEURYSM RUPTURE (VERSIONS) | 2018 |
|
RU2694544C1 |
| METHOD FOR TREATMENT OF CEREBRAL VASOSPASM IN ANEURYSMAL SUBARACHNOID HEMORRHAGE | 2020 |
|
RU2763254C1 |
| CONSEQUENCES OF LUNG DAMAGE INDUCED BY ARTIFICIAL BLOOD CIRCULATION | 2017 |
|
RU2762593C2 |
| SYSTEM OF INTRAVENTRICULAR DRUG DELIVERY TO IMPROVE OUTCOME AFTER BRAIN DAMAGE, VIOLATING CEREBRAL BLOOD CIRCULATION | 2012 |
|
RU2606169C2 |
| INTRAVENOUS INTRODUCTION OF CITRULLINE DURING SURGICAL INTERVENTION | 2016 |
|
RU2733738C2 |
| ARGININE DEIMINASE ENCAPSULATED IN ERYTHROCYTES, AND THEIR USE IN TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY | 2018 |
|
RU2773220C2 |
| METHODS OF TREATING WITH USING CITRULLINE | 2007 |
|
RU2444355C2 |
